Farallon Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,188,000
| Closed | -$180M | – | 143 |
|
|
2024
Q4 | $180M | Buy |
+3,188,000
| New | +$180M | 0.81% | 38 |
|
|
2021
Q1 | – | Sell |
-250,000
| Closed | -$15.5M | – | 238 |
|
|
2020
Q4 | $15.5M | Sell |
250,000
-3,500,000
| -93% | -$217M | 0.09% | 96 |
|
|
2020
Q3 | $226M | Buy |
3,750,000
+125,000
| +3% | +$7.54M | 1.56% | 23 |
|
|
2020
Q2 | $213M | Buy |
+3,625,000
| New | +$213M | 1.71% | 21 |
|
|
2018
Q1 | – | Sell |
-1,192,500
| Closed | -$73.1M | – | 90 |
|
|
2017
Q4 | $73.1M | Sell |
1,192,500
-162,500
| -12% | -$9.96M | 0.59% | 33 |
|
|
2017
Q3 | $86.4M | Buy |
+1,355,000
| New | +$86.4M | 0.77% | 33 |
|
|
2017
Q2 | – | Sell |
-442,500
| Closed | -$24.1M | – | 82 |
|
|
2017
Q1 | $24.1M | Buy |
442,500
+132,500
| +43% | +$7.21M | 0.26% | 50 |
|
|
2016
Q4 | $18.1M | Buy |
+310,000
| New | +$18.1M | 0.21% | 43 |
|